+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Enzyme-linked Immunosorbent Assay Testing Market by Product (Instruments, Kits, Reagents), Assay Type (Competitive, Direct, Indirect), End Users, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989693
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Enzyme-linked immunosorbent assay (ELISA) testing is transforming operational efficiency, quality assurance, and diagnostic precision across healthcare, research, and industry. As stakeholders adapt to new technologies and market dynamics, understanding key drivers and strategic imperatives has never been more critical.

Market Snapshot: Enzyme-linked Immunosorbent Assay Testing Market Overview

The Enzyme-linked Immunosorbent Assay Testing Market grew from USD 552.58 million in 2024 to USD 593.09 million in 2025. The market is projected to continue expanding at a CAGR of 7.13%, ultimately reaching USD 835.38 million by 2030. This momentum reflects steady investment in laboratory automation, diagnostic innovation, and highly specific assay platforms, positioning ELISA at the core of diverse analytical workflows globally.

Scope & Segmentation of the ELISA Testing Market

  • Product Types: Instruments such as microplate readers and washers; automated and manual kits; and a range of reagents including antibodies, enzymes, and substrates; as well as data analysis software and maintenance services.
  • Assay Formats: Competitive, direct, indirect, and sandwich ELISA types, each supporting distinct testing requirements and workflow integration.
  • End Users: Academic and research organizations, contract research organizations, hospitals and diagnostic facilities, and pharmaceutical and biotech companies.
  • Application Domains: Disease testing, drug discovery, environmental testing, and food safety and quality monitoring.
  • Regional Coverage: Americas (with key states such as California, Texas, and New York), Europe, Middle East & Africa (covering major markets such as Germany, the United Kingdom, and Saudi Arabia), and Asia-Pacific (including China, India, Japan, and Southeast Asian economies).

Enzyme-linked Immunosorbent Assay Testing: Key Takeaways for Decision-Makers

  • Automation is steadily replacing manual workflows, allowing skilled personnel to focus on analytical optimization and interpretation.
  • The convergence of biotechnology with advanced digital analytics is broadening the application scope into drug development and environmental monitoring.
  • Larger organizations are favoring comprehensive solution ecosystems, integrating hardware, consumables, software, and maintenance for operational continuity.
  • Regional differences shape procurement strategies; for instance, high-throughput technologies are being rapidly adopted in Asia-Pacific, while the Americas prioritize regulatory alignment and integrated platforms.
  • Multiplexing and miniaturization are gaining traction, enabling higher throughput, reduced reagent use, and improved assay customization without sacrificing sensitivity.

Tariff Impact on Supply Chains and Cost Structures

New United States tariffs introduced in 2025 have altered cost structures for ELISA testing suppliers and end users. Import duties on core components and reagents are compressing margins and causing procurement delays. Laboratories and manufacturers are responding by evaluating local production and alternative sourcing to ensure operational continuity and reduce exposure to international fluctuations. These adjustments are also reinforcing demand for vertically integrated services and supply chain partnerships.

Methodology & Data Sources

This report leverages a rigorous, multi-modal research design. Primary insights were collected through stakeholder interviews at academic, CRO, clinical, and industry sites. These were supplemented with expert consultations in assay development and regulatory affairs. Secondary sources included peer-reviewed literature, patent filings, and quantitative device usage analyses, validated through a triangulation and review process.

Why This Report Matters to Senior Leaders

  • Enables confident investment decisions by detailing segment-specific opportunities and emerging technology adoption across the ELISA ecosystem.
  • Provides robust strategies for navigating cost pressures, supply challenges, and evolving regulatory requirements in regional and global contexts.

Conclusion

ELISA testing markets are being reshaped by innovation, adaptive supply strategies, and changing regional dynamics. Forward-looking organizations leveraging integrated technologies and collaborative models will be well positioned for sustained leadership and growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of high-throughput automated ELISA platforms for large scale infectious disease screening
5.2. Integration of microfluidic lab-on-a-chip technology to miniaturize and accelerate ELISA assays
5.3. Development of multiplex ELISA panels for simultaneous detection of multiple biomarkers in oncology research
5.4. Emergence of digital ELISA systems enhancing sensitivity and quantitative protein analysis at single molecule levels
5.5. Expansion of point of care ELISA testing devices enabling rapid diagnostics in resource limited settings
5.6. Leveraging AI and machine learning to optimize ELISA assay design and data interpretation workflows
5.7. Growth of demand for green ELISA reagents and sustainable manufacturing processes in test kit production
5.8. Customization of ELISA assays for personalized medicine biomarker validation and therapeutic monitoring
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Enzyme-linked Immunosorbent Assay Testing Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Microplate Readers
8.2.2. Microplate Washers
8.3. Kits
8.3.1. Automated Kits
8.3.2. Manual Kits
8.4. Reagents
8.4.1. Antibodies
8.4.2. Enzymes
8.4.3. Substrates
8.5. Software And Services
8.5.1. Data Analysis Software
8.5.2. Maintenance Services
9. Enzyme-linked Immunosorbent Assay Testing Market, by Assay Type
9.1. Introduction
9.2. Competitive
9.3. Direct
9.4. Indirect
9.5. Sandwich
10. Enzyme-linked Immunosorbent Assay Testing Market, by End Users
10.1. Introduction
10.2. Academic And Research
10.3. Contract Research Organizations
10.4. Hospitals And Diagnostics
10.5. Pharmaceutical And Biotech
11. Enzyme-linked Immunosorbent Assay Testing Market, by Application
11.1. Introduction
11.2. Disease Testing
11.3. Drug Discovery
11.4. Environmental Testing
11.5. Food Safety And Quality
12. Americas Enzyme-linked Immunosorbent Assay Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Merck KGaA
15.3.4. Bio-Rad Laboratories, Inc.
15.3.5. Agilent Technologies, Inc.
15.3.6. PerkinElmer, Inc.
15.3.7. Bio-Techne Corporation
15.3.8. Becton, Dickinson and Company
15.3.9. Abcam plc
15.3.10. Enzo Biochem, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: RESEARCHAI
FIGURE 24. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE WASHERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE WASHERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MANUAL KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBSTRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY FOOD SAFETY AND QUALITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY FOOD SAFETY AND QUALITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 114. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 115. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 116. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 117. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 118. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 119. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 120. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 121. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 124. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 125. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 260. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 261. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 262. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 263. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 264. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 265. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 266. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 267. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 268. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 269. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 270. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 271. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD M

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation
  • Becton, Dickinson and Company
  • Abcam plc
  • Enzo Biochem, Inc.

Table Information